ACHE and Alzheimer disease: A comprehensive understanding of the interactions between CTN and proteins and their inhibitory effects on AChE and quantified brain AchE, antioxidant, and cognitive function in scopolamine-induced AD mice could prove advantageous in advancing drug design and development for treating AD.